AskBio

AskBio receives FDA Fast Track and MHRA Innovation Passport Designations for AB-1005 Investigational GDNF Gene Therapy for Parkinson’s Disease
Drugs.com
Thu, 07/11/24 - 10:55 pm
Bayer
AskBio
FDA
AB-1005
Parkinson's Disease
fast track status
FDA fast-tracks AskBio’s heart failure gene therapy
Pharmaphorum
Thu, 04/18/24 - 11:14 am
FDA
Bayer
AskBio
heart failure
gene therapy
fast track
AB-1002
Bayer and AskBio begin Phase II congestive heart failure treatment trial
Clinical Trials Arena
Fri, 01/12/24 - 09:54 am
Bayer
AskBio
congestive heart failure
clinical trials
AB-1002
Bayer's AskBio checks off another early win for gene therapy platform with Parkinson's safety data
Fierce Biotech
Thu, 01/4/24 - 10:12 am
Bayer
AskBio
gene therapy
Parkinson's Disease
BrainVectis gains approval for Phase I/II Huntington’s gene therapy trial
Clinical Trials Arena
Wed, 08/24/22 - 10:46 pm
AskBio
BrainVectis
clinical trials
Huntington's disease
Bayer-owned AskBio will shift focus toward its doggybone DNA in restructure with Touchlight
Endpoints
Wed, 02/9/22 - 10:47 pm
AskBio
Bayer
DNA
dbDNA
Touchlight
AskBio, Syndax and Catalyst All on the Fast Track
BioSpace
Mon, 06/28/21 - 06:56 pm
FDA
fast track status
AskBio
Bayer
gene therapy
LGMD
Syndax Pharma
leukemia
Catalyst Biosciences
episodic bleeding
Bayer’s gene therapy juggling act
EP Vantage
Mon, 02/8/21 - 10:35 am
Bayer
gene therapy
AskBio
How 2 scientific pioneers teamed up to run AskBio, Bayer's new gene therapy division
BioPharma Dive
Thu, 01/21/21 - 11:39 pm
Bayer
AskBio
M&A
gene therapy
Bayer to buy AskBio for $2B in bid to become a gene therapy player
BioPharma Dive
Mon, 10/26/20 - 11:16 am
Bayer
M&A
AskBio
gene therapy
AskBio Reels In $235M to Advance Gene Therapy Clinical Trials
Xconomy
Thu, 04/11/19 - 12:31 pm
gene therapy
AskBio
Asklepios BioPharmaceutical
gene therapies